BRAINSTORM CELL THERAPEUTICS INC. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Brainstorm Cell Therapeutics Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Brainstorm Cell Therapeutics Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $166K, a 57% decline year-over-year.
  • Brainstorm Cell Therapeutics Inc. annual Operating Lease, Payments for 2023 was $1.31M, a 14.6% decline from 2022.
  • Brainstorm Cell Therapeutics Inc. annual Operating Lease, Payments for 2022 was $1.54M, a 44.4% decline from 2021.
  • Brainstorm Cell Therapeutics Inc. annual Operating Lease, Payments for 2021 was $2.77M, a 94.4% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.